Citation Impact
Citing Papers
Guidelines on oral anticoagulation: third edition
1998
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Risk Factors for Venous Thromboembolism
2003 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Human Adenovirus Infection in Kawasaki Disease: A Confounding Bystander?
2012
Heparin in the Treatment of Thromboembolic Stroke
1989
Intracerebral haemorrhage
2009 Standout
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients
2005 Standout
What is “quality of evidence” and why is it important to clinicians?
2008 Standout
Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
1998 Standout
Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2
2004 StandoutNature
Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients
1991
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Effects of Computerized Clinical Decision Support Systems on Practitioner Performance and Patient Outcomes
2005 Standout
Antithrombotic Therapy for VTE Disease
2016 Standout
Exercise Standards for Testing and Training
2013 Standout
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Different Predictors of Neurological Worsening in Different Causes of Stroke
1998
A Randomized Comparison of a Computer-Based Dosing Program with a Manual System to Monitor Oral Anticoagulant Therapy
1998
Intra-arterial Prourokinase for Acute Ischemic Stroke
1999 Standout
Risk Factors for Recurrent Syncope and Subsequent Fatal or Near-Fatal Events in Children and Adolescents With Long QT Syndrome
2011
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2008
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2004
Antithrombotic Therapy for VTE Disease
2012 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
RGD modified polymers: biomaterials for stimulated cell adhesion and beyond
2003 Standout
Carotid endarterectomy for unstable and compelling neurologic conditions: Do results justify an aggressive approach?
1994
Anticoagulants for acute ischaemic stroke
2008
Blood and tissue compatibility of modified polyester: Thrombosis, inflammation, and healing
1998
Effectiveness of heparin treatment for progressing ischaemic stroke: before and after study
2000
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Progressing Neurological Deficit Secondary to Acute Ischemic Stroke
1995
Usefulness of QRST time-integral values of 12-lead electrocardiograms in diagnosing healed myocardial infarction complicated by left bundle branch block
1991 StandoutNobel
Antithrombotic Therapy for Venous Thromboembolic Disease
2001 Standout
Anti–VLA-4 antibody reduces intimal hyperplasia in the endarterectomized carotid artery in nonhuman primates
1997
Hemorrhagic Complications of Anticoagulant Treatment
1998
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
1998 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2004
Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy
1989
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
1998
Guidelines for the Early Management of Adults With Ischemic Stroke
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Controlled Trial of Ancrod in Ischemic Stroke
1983
Effect of oestrogens on postexercise electrocardiogram.
1976
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Clinical and Angiographic Features of Carotid Transient Ischemic Attacks
1977
Medical treatment of transient ischemic attacks: does it influence mortality?
1988
Can old people on oral anticoagulants be safely managed as out-patients?
1988
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
1991 Standout
Prospective comparative study of computer programs used for management of warfarin.
1993
Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks
1995
IS A CONTROLLED TRIAL OF LONG-TERM ORAL ANTICOAGULANTS IN PATIENTS WITH STROKE AND NON-RHEUMATIC ATRIAL FIBRILLATION WORTHWHILE?
1986
THE SIGNIFICANCE OF HAEMORRHAGE DURING THE TREATMENT OF PATIENTS WITH THE COUMARIN ANTICOAGULANTS
1958
Intracranial hemorrhage and infarction in anticoagulated patients with prosthetic heart valves.
1978
Clinical features of recurrent embolization in acute cardioembolic stroke.
1993
Hemorrhagic complications of long-term anticoagulant therapy for ischemic cerebral vascular disease.
1986
Maternal and fetal sequelae of anticoagulation during pregnancy
1980
Anticoagulant Therapy
1963
Antithrombotic Therapy in Atrial Fibrillation
1989
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1989
THE SIGNIFICANCE OF NONBACTERIAL THROMBOTIC ENDOCARDITIS: AN AUTOPSY AND CLINICAL STUDY OF 78 CASES
1957
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis
1991 Standout
Anticoagulant-induced intracerebral bleeding in brain ischemia
2009
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.
1994
Systematic Reviews: Synthesis of Best Evidence for Clinical Decisions
1997 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Problems Associated with Long-Term Anticoagulant Therapy
1962
Management of Anticoagulation in Outpatients
1977
Therapeutic level in long term anticoagulant therapy after myocardial infarction
1963
CORONARY MIMICRY: NORMAL VARIANTS, AND PHYSIOLOGIC, PHARMACOLOGIC AND PATHOLOGIC INFLUENCES THAT SIMULATE CORONARY PATTERNS IN THE ELECTROCARDIOGRAM
1960
Failure of heparin to prevent progression in progressing ischemic infarction.
1988
Hemorrhagic Complications of Anticoagulant Treatment
1992
EXPERIENCES WITH LONG-TERM ANTICOAGULANT TREATMENT
1959
Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
1993 Standout
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1986
Thrombophlebitis associated with pregnancy
1971
Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.
1988
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Hazards of Oral Anticoagulants During Pregnancy
1980
The Role of Alpha and Beta Platelet-Derived Growth Factor Receptor in the Vascular Response to Injury in Nonhuman Primates
1999
Massive Hemorrhage Complicating Age-Related Macular Degeneration
1986
Non-rheumatic atrial fibrillation as a risk factor for stroke.
1985
Cerebral Arterial Insufficiency
1965
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
1997 Standout
Hemorrhagic Complications of Anticoagulant Treatment
1995
Guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.
1994
Antithrombotic Therapy in Atrial Fibrillation
1992
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Anticoagulant vs anti-platelet therapy as prophylactic against cerebral infarction in transient ischemic attacks.
1980
Warfarin‐associated embryopathy in a 17‒week‐old abortus
1976
DURATION OF ANTICOAGULANT THERAPY IN VENOUS THROMBOEMBOLISM
1972
Coronary Artery Disease in Peripheral Vascular Patients
1984 Standout
Antithrombotic Therapy for Cerebrovascular Disorders
1995
The Impact of Recanalization on Ischemic Stroke Outcome
2007 Standout
Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases
2002 Standout
Intravenous Heparin for the Prevention of Stroke Progression in Acute Partial Stable Stroke: A Randomized Controlled Trial
1986
Antiinflammatory Properties of HDL
2004 Standout
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
1990 Standout
Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality
2005 Standout
Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
1988
Menopause and Risk of Cardiovascular Disease
1976 Standout
Works of Ellen McDevitt being referenced
CEREBRAL VASCULAR DISEASES: THEIR SIGNIFICANCE, DIAGNOSIS AND PRESENT TREATMENT, INCLUDING THE SELECTIVE USE OF ANTICOAGULANT SUBSTANCES
1954
TREATMENT OF CEREBRAL EMBOLISM.
1965
A Cooperative Study of Cerebrovascular Disease
1959
Analysis of factors affecting the recurrence of thromboembolism off and on anticoagulant therapy
1958
The electrocardiogram in scleroderma: Analysis of 60 cases and review of the literature
1958
Stroke and Blood Coagulation
1973
The use of anticoagulants for thrombophlebitis during pregnancy
1959
CEREBRAL VASCULAR DISEASES THEIR SIGNIFICANCE, DIAGNOSIS, AND PRESENT TREATMENT, INCLUDING THE SELECTIVE USE OF ANTICOAGULANT SUBSTANCES
1954
EFFECTS OF COUMARIN COMPOUNDS ON THE FETUS
1971
USE OF ANTICOAGULANTS IN TREATMENT OF CEREBRAL VASCULAR DISEASE
1958
Anticoagulant therapy in cerebral infarction
1962
A clinical trial of premarin in cerebrovascular disease
1967
Long-Term Anticoagulant Therapy
1954
Problems of anticoagulant therapy in cerebrovascular disease
1959
Blood-Clotting Mechanisms of Nonhuman Primates
1972